Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease

doi:10.3748/wjg.v20.i48.18240

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 48

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7381)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

504

WORD

199

HTML

4218

Figures (1-3)

210

Tables (1-5)

197

Sum=5328

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1114

Download

939

Sum=2053

Dec 28, 2014 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (28)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Dec 28, 2014; 20(48): 18240-18248
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18240

Table 3 Expression of CD133, CD90 and CK19

		HCC (n = 70)	CH (n = 30)	Control (n = 33)
CD133	mean ± SD	75.34 ± 83.67	1205.57 ± 952.59	205.97 ± 71.88
CD133	Median	47.5^a^c	1245.0^a	200
CK19	mean ± SD	358.09 ± 335.30	392.20 ± 886.61	0.00
CK19	Median	215.5^a	64.5^a	0.0
CD90	mean ± SD	82.75 ± 15.30	43.20 ± 18.50	0.00
CD90	Median	65.3^a^c	34.1^a	0.0

CK: Cytokeratin; CH: Chronic hepatitis; HCC: Hepatocellular carcinoma; SD: Standard deviation.

^aP < 0.05 vs controls;

^cP < 0.05 vs CH.

Citation: Bahnassy AA, Zekri ARN, El-Bastawisy A, Fawzy A, Shetta M, Hussein N, Omran D, Ahmed AAS, El-Labbody SS. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease. World J Gastroenterol 2014; 20(48): 18240-18248
URL: https://www.wjgnet.com/1007-9327/full/v20/i48/18240.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i48.18240